GUILIN PHARMACEUTICAL CO., LTD.

Since the 1960s to now, it has been the largest pharmaceutical manufacturing enterprise in Guangxi Zhuang Autonomous Region all along, and has been listed as one of the key pharmaceutical enterprises of the state by China Pharmaceutical Industrial Association and China National Pharmaceutical Industrial Co., Ltd. Artesunate, a hi-tech product developed by the company with independent intellectual property rights has been approved as Class I new medicine by the Ministry of Health in 1987 with a patent for product invention, and in December 2005, it passed the supplier pre-qualification of WHO. The combination therapy of Artesunate plus Amodiaqiune is recommended by some authoritative organizations such as Global Roll Back Malaria Committee and WHO, and has obtained WHO and GMP certifications. Production lines for Bumetanide, Levamisol, Levamisole Phosphate also have passed the FDA quality verifications of the US.
Having experienced a century of pioneering and progressing, Guilin Pharmaceutical Co., Ltd has acquired good quality control systems and technical research and development abilities. Its distribution network covers all parts of the country. A number of its products are exported to more than 50 countries in Europe, America, Africa and Southeast Asia.

Business Type

Manufacturer

Website

www.guilinpharma.com

Establish Year

1960

Certificates

HACCP

Major markets

Southeast Asia; Africa; Western Europe;

Number of employees

500 - 1,000

Anual sales

50,000,000 - 100,000,000 UDS

Legal representative

for premium members only

Business addresss

No. 17 Shanghai Road, Guilin, Guangxi, China

4160655_781752
Product Name

4160655_781752

Website

www.guilinpharma.com

Contact person

Mr. YU XIAO

Phone

86-773-3558031

Address

No. 17 Shanghai Road, Guilin, Guangxi, China

City

Guilin

State/Region

Guangxi

Postal code

541002